Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | PPARG | P37231 | 8/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.48 |
| ▸ | PTGES | O14684 | 1/20 | 0.48 |
| ▸ | PPARA | Q07869 | 7/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | MTNR1A | P48039 | 5/20 | 0.46 |
| ▸ | MTNR1B | P49286 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7142498 | 0.91 | LMNA (0.51) | FOLH1LMNAPPARGALOX5PTGES | |
| SCHEMBL1565567 | 0.88 | PPARG (0.61) | FOLH1LMNAPPARGALOX5PTGES | |
| SCHEMBL9092823 | 0.86 | PPARG (0.55) | FOLH1LMNAPPARGALOX5PTGES | |
| SCHEMBL6393068 | 0.85 | FOLH1 (0.41) | FOLH1PPARGALOX5PTGESPPARA | |
| SCHEMBL30475592 | 0.81 | SMN1; SMN2 (0.59) | LMNAPPARGPPARATSHRMAPK1 | |
| Aminodiphenylmethane SCHEMBL6631422 | 0.81 | MTNR1A (0.45) | FOLH1LMNAPPARGPPARAL3MBTL1 | |
| SCHEMBL5718636 | 0.78 | KMT2A (0.55) | LMNAPPARGALOX5PTGESPPARA | |
| SCHEMBL1566435 | 0.77 | PPARG (0.61) | FOLH1PPARGALOX5PTGESPPARA | |
| SCHEMBL5053288 | 0.76 | FOLH1 (0.59) | FOLH1PPARGALOX5PTGESPPARA | |
| SCHEMBL940490 | 0.74 | PPARG (0.58) | PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104619717-B | The synthesis of β-corner simulation peptide cyclic compound | 米梅奥亨制药公司 | 2019-04-02 | — | — | CN | claimed |
| CN-104619717-A | Synthesis of beta-turn peptidomimetic cyclic compounds | MIMETOGEN PHARMACEUTICALS INC | 2015-05-13 | — | — | CN | claimed |
| US-7166696-B2 | Solid phase synthesis supports and methods | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-01-23 | — | — | US | claimed |
| US-20040265899-A1 | Solid phase synthesis supports and methods | 3M INNOVATIVE PROPERTIES COMPANY | 2004-12-30 | — | — | US | claimed |
| US-6787635-B2 | azlactone-functionalized support such as a crosslinked polymer containing an alkenyl azlactone; use making combinatorial libraries | 3M INNOVATIVE PROPERTIES COMPANY | 2004-09-07 | — | — | US | claimed |
| EP-1373167-A2 | SOLID PHASE SYNTHESIS SUPPORTS AND METHODS | 3M Innovative Properties Company (US) | 2004-01-02 | — | — | EP | claimed |
| US-20020173051-A1 | Solid phase synthesis supports and methods | 3M INNOVATIVE PROPERTIES COMPANY | 2002-11-21 | — | — | US | claimed |
| WO-2002081078-A2 | SOLID PHASE SYNTHESIS SUPPORTS AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2002-10-17 | — | — | WO | claimed |
| EP-4707386-A1 | ARTIFICIAL VIRUS CAPSID | AGC INC. (JP) | 2026-03-11 | — | — | EP | disclosed |
| US-20260049107-A1 | ARTIFICIAL VIRAL CAPSID | AGC Inc. (JP) | 2026-02-19 | — | — | US | disclosed |
| EP-4685154-A1 | POLYPEPTIDE DERIVED FROM TRIDEGIN | Rheinische Friedrich-Wilhelms-Universität Bonn (DE) | 2026-01-28 | — | — | EP | disclosed |
| WO-2024228371-A1 | ARTIFICIAL VIRUS CAPSID | ＡＧＣ株式会社 | 2024-11-07 | — | — | WO | disclosed |
| US-20240287131-A1 | PEPTIDE | AGC Inc. (JP) | 2024-08-29 | — | — | US | disclosed |
| EP-4406961-A1 | PEPTIDE | AGC INC. (JP) | 2024-07-31 | — | — | EP | disclosed |
| US-5891737-A | ORTHOGONALLY PROTECTED TRIFUNCTIONAL SCAFFOLDS FOR SOLID PHASE SYNTHESIS OF PEPTIDOMIMETIC COMBINATORIAL LIBRARY | ZYMOGENETICS, INC. (US) | 1999-04-06 | — | — | US | disclosed |
| EP-0788370-A4 | CYCLIC SEMI-RANDOM PEPTIDE LIBRARIES | SMITHKLINE BEECHAM CORP (US) | 1998-07-08 | — | — | EP | disclosed |
| EP-0788370-A1 | CYCLIC SEMI-RANDOM PEPTIDE LIBRARIES | SMITHKLINE BEECHAM CORPORATION (US) | 1997-08-13 | — | — | EP | disclosed |
| US-5646285-A | ORTHOGONALLY PROTECTED COMPOUNDS | ZYMOGENETICS, INC. (US) | 1997-07-08 | — | — | US | disclosed |
| WO-1996040732-A1 | COMBINATORIAL NON-PEPTIDE LIBRARIES | ZYMOGENETICS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1995001800-A1 | CYCLIC SEMI-RANDOM PEPTIDE LIBRARIES | SMITHKLINE BEECHAM CORPORATION (US) | 1995-01-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240287131-A1 | PEPTIDE | SSTR5, SSTR4, NGLY1 | FOLH1 920/4885LMNA 4668/4885PPARG 4483/4885 |
| US-20260049107-A1 | ARTIFICIAL VIRAL CAPSID | ZC3HAV1L, ZFR, SLC39A11 | FOLH1 3225/4885LMNA 3737/4885PPARG 3162/4885 |
| US-20020173051-A1 | Solid phase synthesis supports and methods | FES, LSS, CCNK | FOLH1 4157/4885LMNA 1506/4885PPARG 4313/4885 |
| US-20040265899-A1 | Solid phase synthesis supports and methods | FES, LSS, CCNK | FOLH1 4157/4885LMNA 1506/4885PPARG 4313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.